Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediately treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Arévalo, A. P., Pagotto, R., Pórfido, J. L., Daghero, H., Segovia, M., Yamasaki, K., Varela, B., Hill, M., Verdes, J. M., Duhalde Vega, M., Bollati-Fogolín, M., Crispo, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010049/
https://www.ncbi.nlm.nih.gov/pubmed/33785846
http://dx.doi.org/10.1038/s41598-021-86679-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010049/
https://www.ncbi.nlm.nih.gov/pubmed/33785846
http://dx.doi.org/10.1038/s41598-021-86679-0

Ejemplares similares